This statistic depicts the number of orphan drugs in the U.S. that were protected by patents or other distinctions as of 2018, by duration of patents or orphan drug exclusivity. According to the data, among those drugs that were still protected by ODE (orphan drug exclusivity) and patent exclusivity, 156 had patents that were longer than their orphan drug exclusivity.
Number of orphan drugs with patent protection and orphan drug exclusivity in the U.S. as of 2018, by duration
Characteristic
Equal
Patent longer
Orphan drug exclusivity longer
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
ODE = orphan drug exclusivity.
Patent protection includes other forms of market exclusivity (e.g., pediatric extension, 505(b)(2)). Comparison of
latest patent and earliest orphan exclusivity dates as the determination of longer duration.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
IQVIA. (December 17, 2018). Number of orphan drugs with patent protection and orphan drug exclusivity in the U.S. as of 2018, by duration [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/979775/orphan-drug-patient-protections-and-exclusivity-us-by-duration/
IQVIA. "Number of orphan drugs with patent protection and orphan drug exclusivity in the U.S. as of 2018, by duration." Chart. December 17, 2018. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/979775/orphan-drug-patient-protections-and-exclusivity-us-by-duration/
IQVIA. (2018). Number of orphan drugs with patent protection and orphan drug exclusivity in the U.S. as of 2018, by duration. Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/979775/orphan-drug-patient-protections-and-exclusivity-us-by-duration/
IQVIA. "Number of Orphan Drugs with Patent Protection and Orphan Drug Exclusivity in The U.S. as of 2018, by Duration." Statista, Statista Inc., 17 Dec 2018, https://www.statista.com/statistics/979775/orphan-drug-patient-protections-and-exclusivity-us-by-duration/
IQVIA, Number of orphan drugs with patent protection and orphan drug exclusivity in the U.S. as of 2018, by duration Statista, https://www.statista.com/statistics/979775/orphan-drug-patient-protections-and-exclusivity-us-by-duration/ (last visited July 22, 2024)
Number of orphan drugs with patent protection and orphan drug exclusivity in the U.S. as of 2018, by duration [Graph], IQVIA, December 17, 2018. [Online]. Available: https://www.statista.com/statistics/979775/orphan-drug-patient-protections-and-exclusivity-us-by-duration/
